How do transurethral needle ablation of the prostate and transurethral microwave thermotherapy compare with transurethral prostatectomy?

Current Urology Reports

Volumn 4, Issue 4, 2003, Pages 297-306

  Gonzalez, Ricardo R ^b   Te, Alexis E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

Benign Prostatic Hyperplasia; International Prostate Symptom Score; International Prostate Symptom Score Score; Maximum Flow Rate; Transurethral Prostatectomy

Indexed keywords

CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; MALE; PATHOPHYSIOLOGY; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TRANSURETHRAL RESECTION; URODYNAMICS;

COST-BENEFIT ANALYSIS; HUMANS; MALE; PROSTATIC HYPERPLASIA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; TRANSURETHRAL RESECTION OF PROSTATE; URODYNAMICS;

EID: 0142166246     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-003-0088-x     Document Type: Article

References (53)

1. Barry MJ: Medical outcomes research and benign prostatic hyperplasia. Prostate Suppl 1990, 3:61–74. DOI: 10.1002/pros.2990170507
2. Fitzpatrick JM, Mebust WK: Minimally invasive and endoscopic management of benign prostatic hyperplasia. In Campbell’s Urology. Edited by Walsh PC. New York: WB Saunders; 2002:1379–1422.
3. Arai Y, Aoki Y, Okubo K, et al.: Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study. J Urol 2000, 164:1206–1211. This study reports the effects of minimally invasive BPH therapies on sexual activity, libido, erectile function, and ejaculation. The authors note the association of ejaculatory function with sexual function. DOI: 10.1016/S0022-5347(05)67142-X
4. Sapozink MD, Boyd SD, Astrahan MA, et al.: Transurethral hyperthermia for benign prostatic hyperplasia: preliminary clinical results. J Urol 1990, 143:944–949.
5. Schulman CC, Zlotta AR: Transurethral needle ablation of the prostate (TUNA): pathological, radiological and clinical study of a new office procedure for treatment of benign prostatic hyperplasia using low-level radiofrequency energy. Semin Urol 1994, 12:205–210.
6. Heaton JP: Radiofrequency thermal ablation of the prostate: the TUNA technique. Tech Urol 1995, 1:3–10.
7. Larson TR: Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy. Urology 2002, 59(suppl 1):12–16. DOI: 10.1016/S0090-4295(01)01557-6
8. Schulman CC, Zlotta AR, Rasor JS, et al.: Transurethral needle ablation (TUNA): safety, feasibility, and tolerance of a new office procedure for treatment of benign prostatic hyperplasia. Eur Urol 1993, 24:415–423.
9. de la Rosette JJ, D’Ancona FC, Debruyne FM: Current status of thermotherapy of the prostate. J Urol 1997, 157:430–438. DOI: 10.1016/S0022-5347(01)65164-4
10. Larson TR, Bostwick DG, Corica A: Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. Urology 1996, 47:463–469. DOI: 10.1016/S0090-4295(99)80478-6
11. Perachino M, Bozzo W, Puppo P, et al.: Does transurethral thermotherapy induce a long-term alpha blockade? An immunohistochemical study. Eur Urol 1993, 23:299–301.
12. Larson TR, Collins JM: An accurate technique for detailed prostatic interstitial temperature-mapping in patients receiving microwave thermal treatment. J Endourol 1995, 9:339–347.
13. Kaplan SA, Shabsigh R, Soldo KA, Olsson CA: Prostatic and periprostatic interstitial temperature measurements in patients treated with transrectal thermal therapy (local intracavitary microwave hyperthermia). J Urol 1992, 147:1562–1565.
14. Larson TR, Bostwick DG, Corica A: Temperature-correlated histopathologic changes following microwave thermoablation of obstructive tissue in patients with benign prostatic hyperplasia. Urology 1996, 47:463–469. DOI: 10.1016/S0090-4295(99)80478-6
15. Bhowmick S: Proceedings of 2001 ASME International Mechanical Engineering Congress and Exposition. New York, November 11–16, 2001.
16. Larson TR, Collins JM, Corica A: Detailed interstitial temperature mapping during treatment with a novel transurethral microwave thermoablation system in patients with benign prostatic hyperplasia. J Urol 1998, 159:258–264. DOI: 10.1016/S0022-5347(01)64078-3
17. Astrahan MA, Ameye F, Oyen R, et al.: Interstitial temperature measurements during transurethral microwave hyperthermia. J Urol 1991, 145:304–308.
18. Blute ML: Microwave thermotherapy for the treatment of benign prostatic hyperplasia. Semin Urol 1994, 12:181–192.
19. Te A, Sa K: Complications of minimally invasive surgery for benign prostatic hypertropy. In Complications in Urologic Surgery: Prevention and Management. Edited by Taneja S. Philadelphia: WB Saunders; 2000:244–256.
20. Dahlstrand C, Walden M, Geirsson G, Pettersson S.: Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 1995, 76:614–618.
21. Albala DM, Fulmer BR, Turk TM, et al.: Office-based transurethral microwave thermotherapy using the TherMatrx TMx-2000. J Endourol 2002, 16:57–61. DOI: 10.1089/089277902753483745
22. Mebust WK, Holtgrewe HL, Cockett AT, Peters PC: Transurethral prostatectomy: immediate and postoperative complications: cooperative study of 13 participating institutions evaluating 3885 patients. J Urol 1989, 141:243–247, J Urol 2002, 167:5–9.
23. Thalmann GN, Mattei A, Treuthardt C, et al.: Transurethral microwave therapy in 200 patients with a minimum followup of 2 years: urodynamic and clinical results. J Urol 2002, 167:2496–2501. DOI: 10.1016/S0022-5347(05)65013-6
24. Ahmed M, Bell T, Lawrence WT, et al.: Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 1997, 79:181–185.
25. d’Ancona FC, Francisca EA, Witjes WP, et al.: Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: longterm results. Br J Urol 1998, 81:259–264.
26. Floratos DL, Kiemeney LA, Rossi L, et al.: Long-term follow-up of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001, 165:1533–1538. Randomized, controlled trial involving 155 patients comparing HE-TUMT with TURP, with a follow-up of up to 3 years. Follow-up data include symptom scores, flow rate, and retreatment rate. HE-TUMT and TURP improve symptoms of obstruction (TURP more so than HE-TUMT). DOI: 10.1016/S0022-5347(05)66343-4
27. Wagrell L, Schelin S, Nordling J, et al.: Feedback microwave thermotherapy versus TURP for clinical BPH: a randomized controlled multicenter study. Urology 2002, 60:292–299. DOI: 10.1016/S0090-4295(02)01740-5
28. Campo B, Bergamaschi F, Corrada P, Ordesi G: Transurethral needle ablation (TUNA) of the prostate: a clinical and urodynamic evaluation. Urology 1997, 49:847–850. DOI: 10.1016/S0090-4295(97)00155-6
29. Ramon J, Lynch TH, Eardley J, et al.: Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: a collaborative multicentre study. Br J Urol 1997, 80:128–134.
30. Rosario DJ, Woo H, Potts KL, et al.: Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol 1997, 80:579–586.
31. Daehlin L, Gustavsen A, Nilsen AH, Mohn J: Transurethral needle ablation for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: outcome after 1 year. J Endourol 2002, 16:111–115. DOI: 10.1089/089277902753619636
32. Bruskewitz R, Issa MM, Roehrborn CG, et al.: A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998, 159:1588–1593. Randomized, controlled trial involving 121 symptomatic BPH patients comparing TUNA with TURP. Symptom scores, postvoid residual urine volumes, flow rates, sexual function, and complications are compared during a 1-year period. Both modalities are effective, but TUNA has fewer adverse effects. DOI: 10.1097/00005392-199805000-00048
33. Roehrborn CG, Burkhard FC, Bruskewitz RC, et al.: The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol 1999, 162:92–97. Randomized, controlled trial involving 121 patients comparing TUNA with TURP in terms of urodynamic parameters at 6 months. TUNA and TURP reduce obstructive urodynamic parameters (TURP more so than TUNA). Baseline urodynamic parameters do not predict degree of symptomatic improvement or patient selection for TUNA. DOI: 10.1097/00005392-199907000-00023
34. Abrams PH, Griffiths DJ: The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 1979, 51:129–134. DOI: 10.1111/j.1464-410X.1979.tb02846.x
35. Wasson JH, Bubolz TA, Lu-Yao GL, et al., for the Patient Outcomes Research Team for Prostatic Diseases: Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. J Urol 2000, 164:1212–1215. DOI: 10.1016/S0022-5347(05)67143-1
36. Hagerty JA, Ginsberg PC, Harmon JD, Harkaway RC: Pretreatment with finasteride decreases perioperative bleeding associated with transurethral resection of the prostate. Urology 2000, 55:684–689. DOI: 10.1016/S0090-4295(00)00454-4
37. Zlotta AR, Peny MO, Matos C, Schulman CC: Transurethral needle ablation of the prostate: clinical experience in patients in urinary acute retention. Br J Urol 1996, 77:391–397.
38. Ackerman SJ, Rein AL, Blute M, et al.: Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part I-methods. Urology 2000, 56:972–980. DOI: 10.1016/S0090-4295(00)00828-1
39. Francisca EA, d’Ancona FC, Hendricks JC, et al.: Quality of life assessment in patients treated with lower energy thermotherapy (Prostasoft 2.0): results of a randomized transurethral microwave thermotherapy versus sham study. J Urol 1997, 158:1839–1844. DOI: 10.1016/S0022-5347(01)64141-7
40. Manyak MJ, Ackerman SJ, Blute ML, et al.: Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy. J Endourol 2002, 16:51–56. DOI: 10.1089/089277902753483736
41. Blute M, Ackerman SJ, Rein AL, et al.: Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II--results. Urology 2000, 56:981–987. DOI: 10.1016/S0090-4295(00)00829-3
42. Laguna MP, Kiemeney LA, Debruyne FM, de la Rosette JJ: Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 2002, 167:1727–1730. DOI: 10.1016/S0022-5347(05)65187-7
43. Djavan B, Seitz C, Roehrborn CG, et al.: Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 2001, 57:66–70. DOI: 10.1016/S0090-4295(00)00854-2
44. Francisca EA, d’Ancona FC, Meuleman EJ, et al.: Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999, 161:486–490. DOI: 10.1016/S0022-5347(01)61930-X
45. Keijzers GB, Francisca EA, D’Ancona FC, et al.: Long-term results of lower energy transurethral microwave thermotherapy. J Urol 1998, 159:1966–1972. DOI: 10.1016/S0022-5347(01)63211-7
46. Lau KO, Li MK, Foo KT: Long-term follow-up of transurethral microwave thermotherapy. Urology 1998, 52:829–833. DOI: 10.1016/S0090-4295(98)00285-4
47. Terada N, Aoki Y, Ichioka K, et al.: Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: response durability and variables potentially predicting response. Urology 2001, 57:701–705. DOI: 10.1016/S0090-4295(00)01118-3
48. Tsai YS, Lin JS, Tong YC, et al.: Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: longterm durability with Prostcare. Eur Urol 2001, 39:688–692. DOI: 10.1159/000052528
49. Daehlin L, Frugard J: Transurethral microwave thermotherapy in the management of lower urinary tract symptoms from benign prostatic obstruction: follow-up after five years. Scand J Urol Nephrol 2000, 34:304–308. DOI: 10.1080/003655900750048314
50. Roehrborn CG, Issa MM, Bruskewitz RC, et al.: Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter US study. Urology 1998, 51:415–421. DOI: 10.1016/S0090-4295(97)00682-1
51. Ohigashi T, Baba S, Ohki T, et al.: Long-term effects of transurethral microwave thermotherapy. Int J Urol 2002, 9:141–145. DOI: 10.1046/j.1442-2042.2002.00439.x
52. Yaman O, Ozdiler E, Sozen S, Gogus O: Transmurally absorbed intravesical chemotherapy with dimethylsulfoxide in an animal model. Int J Urol 1999, 6:87–92. DOI: 10.1046/j.1442-2042.1999.00623.x
53. d’Ancona FC, Francisca EA, Witjes WP, et al.: High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of follow-up. J Urol 1997, 158:120–125. DOI: 10.1097/00005392-199707000-00035